Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [IR] Samsung Electro-Mechanics (009150) – Q4 2024 Earnings Presentation / 2025-01-24 IR Room
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Meeting / 2026-03-10 Semiconductors
  • [Disclosure] Samsung Electro-Mechanics (009150) – Consolidated Earnings Announcement (Provisional) / 2026-01-23 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – (Correction) Acquisition of Shares in Other Corporation / 2024-11-26 Disclosures
  • [Disclosure] Celltrion (068270) – Submission of Application for Phase 3 Clinical Trial Plan for CT-P44 (Darzalex Biosimilar) in the US / 2024-12-02 Disclosures
  • [Disclosure] Jusung Engineering(036930) – Provisional Sales Performance (Consolidated Financial Statements) / 2024-05-02 Semiconductors
  • [Disclosure] SK Square (402340) – Results of General Meeting of Shareholders / 2024-03-28 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment & Securities | Macro/Political Risks · Valuation Adjustment · Target Price Lowered / 2024-12-09 Semiconductors

Category: Disclosures

[Disclosure] Hanwha Ocean (042660) – Decision on Debt Guarantee for Others / 2025-10-10

Posted on October 10, 2025August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Decision on Debt Guarantee for Others / 2025-10-10

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing is a correction disclosure confirming the official start and end dates of the debt guarantee provided by Hanwha Ocean for the new loan of its U.S. affiliate, Hanwha Philly Shipyard Inc. 📊 Key Filing Details & Key Figures Summary 1. Correction Details & Reason…

Read More “[Disclosure] Hanwha Ocean (042660) – Decision on Debt Guarantee for Others / 2025-10-10” »

Disclosures, Shipbuilding

[Disclosure] Hanwha Ocean (042660) – (Correction) Sales and Supply Contract / 2025-10-10

Posted on October 10, 2025August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – (Correction) Sales and Supply Contract / 2025-10-10

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Ocean filed a correction disclosure regarding its contract for one Very Large LPG/Ammonia Carrier with an Oceanian shipowner, revising the contract completion date to May 13, 2026, from September 30, 2026. 📊 [Key Disclosure Details & Financial Summary] 1. Correction Disclosure Overview 2. Contract Period…

Read More “[Disclosure] Hanwha Ocean (042660) – (Correction) Sales and Supply Contract / 2025-10-10” »

Disclosures, Shipbuilding

[Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Host / 2025-10-10

Posted on October 10, 2025August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Host / 2025-10-10

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN will host an overseas Non-Deal Roadshow (NDR) in Hong Kong, sponsored by CLSA, targeting major foreign institutional investors to present its platform technologies and pipeline status/plans. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌 Verification of Platform Technologies…

Read More “[Disclosure] ALTEOGEN (196170) – Investor Relations (IR) Host / 2025-10-10” »

Disclosures, Bio & Healthcare

[Disclosure] ALTEOGEN (196170) – Receipt of Milestone Payment Related to ALT-B4 License Agreement / 2025-10-01

Posted on October 10, 2025August 5, 2026 By K-STOCK Editor
[Disclosure] ALTEOGEN (196170) – Receipt of Milestone Payment Related to ALT-B4 License Agreement / 2025-10-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary ALTEOGEN announced that it is scheduled to receive a milestone payment of USD 25M (approx. KRW 35.06B) following US FDA marketing approval for the subcutaneous (SC) formulation of Pembrolizumab using ALT-B4 licensed to MSD. 📊 [Key Disclosure Details & Major Figures Summary] 📝 Editor’s Comment (Key…

Read More “[Disclosure] ALTEOGEN (196170) – Receipt of Milestone Payment Related to ALT-B4 License Agreement / 2025-10-01” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-10-10

Posted on October 10, 2025August 9, 2026 By K-STOCK Editor
[Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-10-10

Fact Source: Financial Supervisory Service DART 💡 Executive Summary Hanwha Aerospace filed a corrective disclosure specifying the end date of its KRW 402.36B guided weapons supply contract with a Middle Eastern Ministry of Defense as October 7, 2028, following the issuance of the Letter of Credit (L/C). 📊 [Key Disclosure Contents & Summary of Figures]…

Read More “[Disclosure] Hanwha Aerospace (012450) – (Correction) Execution of Single Sales or Supply Contract / 2025-10-10” »

Disclosures, Defense

[Disclosure] Samsung Biologics (207940) – Investor Caution Notice on Stock Futures and Options / 2025-10-10

Posted on October 10, 2025August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Investor Caution Notice on Stock Futures and Options / 2025-10-10

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has issued an investor caution notice disclosing that, due to its corporate spin-off decision, the final trading day for stock futures and options (Nov ’25 through Sep ’26 contracts) will be changed to October 29, 2025, and new contract months will not be listed…

Read More “[Disclosure] Samsung Biologics (207940) – Investor Caution Notice on Stock Futures and Options / 2025-10-10” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-10-02

Posted on October 2, 2025August 11, 2026 By K-STOCK Editor
[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-10-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanwha Systems has signed a supply contract worth approximately KRW 357.3B with the Defense Acquisition Program Administration (DAPA) for L-SAM mass production (multi-function radar) and 32 other items. This represents 12.74% of its 2024 consolidated revenue. 📊 [Key Disclosure Details & Financial Highlights] 📝 Editor’s Comment…

Read More “[Disclosure] Hanwha Systems (272210) – Sales / Supply Contract / 2025-10-02” »

Disclosures, Defense

[Disclosure] Hanmi Semiconductor (042700) – Other Major Management Matters (Voluntary Disclosure) / 2025-10-02

Posted on October 2, 2025July 31, 2026 By K-STOCK Editor
[Disclosure] Hanmi Semiconductor (042700) – Other Major Management Matters (Voluntary Disclosure) / 2025-10-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Hanmi Semiconductor is establishing a wholly-owned subsidiary, ‘HANMI SINGAPORE Pte. Ltd.’, with a total investment of SGD 648,798 (approx. KRW 700M) to enhance local response capabilities for global customers alongside the growth of the AI memory semiconductor market. 📊 [Key Disclosure Contents & Summary of Figures]…

Read More “[Disclosure] Hanmi Semiconductor (042700) – Other Major Management Matters (Voluntary Disclosure) / 2025-10-02” »

Semiconductors, Disclosures

[Disclosure] Samsung Biologics (207940) – Resolution on Convening General Meeting of Shareholders / 2025-10-02

Posted on October 2, 2025August 7, 2026 By K-STOCK Editor
[Disclosure] Samsung Biologics (207940) – Resolution on Convening General Meeting of Shareholders / 2025-10-02

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary Samsung Biologics has disclosed a board resolution to convene the 15th Extraordinary General Meeting of Shareholders on October 17, 2025, at Songdo Convensia to vote on the approval of the spin-off plan. 📊 [Key Disclosure Details & Financial Figures] 📝 Editor’s Comment (Key Follow-up Checkpoint) 📌…

Read More “[Disclosure] Samsung Biologics (207940) – Resolution on Convening General Meeting of Shareholders / 2025-10-02” »

Disclosures, Bio & Healthcare

[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-10-01

Posted on October 1, 2025August 8, 2026 By K-STOCK Editor
[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-10-01

Fact Source: Financial Supervisory Service DART 💡 3-Second Summary This filing discloses that Hanwha Ocean signed a construction contract for one LNG Carrier (LNGC) worth approximately KRW 353.4B with a North American shipowner. 📊 Key Filing Details & Key Figures Summary 1. Key Contract Details 2. Counterparty & Terms 3. Other Key Reference Information 📝…

Read More “[Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-10-01” »

Disclosures, Shipbuilding

Posts pagination

Previous 1 … 92 93 94 … 252 Next
  • [Research] Samsung Electronics (005930) – Yuanta | 2Q26 OP KRW 86.8T · Memory Price Momentum · Target Price Upgrade / 2026-04-30 RESEARCH
  • [Disclosure] Celltrion (068270) – Approval of Phase 3 Clinical Trial Plan (Part 1) in Europe for CT-P13 SC (Pediatric Ulcerative Colitis) / 2024-06-18 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – iM Hi Investment | Chinese Mobile Rebound · PC Restocking Potential · On-Device AI Spec Upgrades / 2024-01-05 RESEARCH
  • [Disclosure] SK Hynix (000660 / SKHY) – Clarification Regarding Rumors or Reports / 2026-07-22 Disclosures
  • [Research] SK hynix (000660 / SKHY) – Daishin | AI Inference · General Server Demand · HBM Leadership / 2025-09-09 RESEARCH
  • [Disclosure] SK Square (402340) – Decision on Disposal of Treasury Shares / 2024-09-30 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Preliminary Sales Results / 2026-07-01 Disclosures
  • [Disclosure] Celltrion (068270) – Final US FDA Approval for Eydenzelt (CT-P42, Eylea Biosimilar) / 2025-10-10 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme